Related Experiment Video

Updated: Aug 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations

Valeria Di Stefano1, Marina Mattiussi, Ada Sacchi

  • 1Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Rome, Italy.

FEBS Letters
|October 11, 2005
PubMed

Insights

Homeodomain-interacting protein kinase 2 (HIPK2) regulates MDM2 through both p53-dependent and p53-independent pathways. HIPK2 controls MDM2 at transcriptional and posttranscriptional levels, impacting DNA damage response.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • MDM2 is a key regulator of the p53 tumor suppressor.
  • DNA damage induces p53 activation and subsequent cellular responses, including apoptosis.
  • HIPK2 is involved in various cellular processes, including DNA damage response and apoptosis.

Purpose of the Study:

  • To elucidate the mechanisms by which HIPK2 regulates MDM2.
  • To investigate the roles of the HIPK2/p53 complex in MDM2 modulation.
  • To understand the contribution of HIPK2 to drug-induced MDM2 activity.

Main Methods:

  • Western blotting to assess protein levels.
  • Immunoprecipitation to study protein interactions.
  • RNA interference to deplete HIPK2.
  • In vitro kinase assays to determine phosphorylation.
  • Subcellular fractionation to analyze protein localization.

Main Results:

  • HIPK2 phosphorylates p53 at Ser46, inhibiting MDM2 transcription in p53-carrying cells.
  • HIPK2 interacts with MDM2 and promotes its nuclear export and proteasomal degradation in a p53-null context.
  • HIPK2 catalytic activity is crucial for the p53-independent regulation of MDM2.
  • Depletion of HIPK2 impairs MDM2 protein degradation following DNA damage.

Conclusions:

  • HIPK2 employs a dual mechanism to downregulate MDM2.
  • Transcriptional regulation occurs via p53Ser46 phosphorylation.
  • Posttranscriptional regulation involves p53-independent nuclear export and degradation of MDM2.
  • HIPK2 plays a significant role in modulating MDM2 activity in response to DNA damage.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...